by Patient Voice Initiative | Sep 3, 2019 | Glossary, T
Part of the Australian Government Department of Health responsible for regulating therapeutic goods including prescription medicines, vaccines, sunscreens, vitamins and minerals, medical devices, blood and blood products. by Patient Voice Initiative | Sep 3, 2019 | Glossary, S
Work that aims to bring together the results of all studies that address a particular research question. They provide a comprehensive and unbiased summary of the research. For example, one clinical trial may not give a clear answer about the effectiveness of a... by Patient Voice Initiative | Sep 3, 2019 | Glossary, S
The probability of observing a treatment effect as large as that seen in the sample (such as in randomised controlled trial), when there is no treatment effect in the wider population, is less than 0.05. HTAI by Patient Voice Initiative | Sep 3, 2019 | Glossary, S
The organisation that makes a submission to PBAC or MSAC or PLAC to have a health technology (such as a medicine or treatment) assessed. It is usually the manufacturer, but patient groups can be sponsors. by Patient Voice Initiative | Sep 3, 2019 | Glossary, S
Any extra effects from a drug, treatment or procedure that are not planned, even when used as instructed. They do not necessarily cause harm. HTAI